US Patent Issued to AMGEN RESEARCH (MUNICH) on Sept. 30 for "PSMA and CD3 bispecific T cell engaging antibody constructs" (German Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,491, issued on Sept. 30, was assigned to AMGEN RESEARCH (MUNICH) GMBH (Munich).

"PSMA and CD3 bispecific T cell engaging antibody constructs" was invented by Tobias Raum (Munich), Markus Munz (Munich), Johannes Brozy (Munich), Peter Kufer (Munich), Patrick Hoffmann (Munich), Matthias Friedrich (Munich), Benno Rattel (Munich), Pamela Bogner (Munich), Andreas Wolf (Munich) and Cornelius Pompe (Munich).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides bispecific antibody constructs of a specific Fc modality characterized by comprising a first domain binding to PSMA, a second domain binding to an extracellular epitope of the ...